Theorem Clinical Research

Clinipace

Karyopharm Therapeutics enters agreement with Clinipace Worldwide

Thursday, April 10, 2014 01:49 PM

Clinipace Worldwide, a global digital CRO (dCRO), has announced that Karyopharm Therapeutics, a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, has entered into a preferred provider agreement with Clinipace to manage several clinical programs, including oncology and wound healing.

More... »


Clinipace Worldwide expands into Asia with acquisition of Choice Pharma

Tuesday, March 11, 2014 09:12 AM

Clinipace Worldwide, a global digital CRO (dCRO), has merged with Choice Pharma, a Pan-Asian CRO.  

More... »


Clinipace, Medfiles partner

Monday, August 5, 2013 11:55 AM

Global CRO Clinipace Worldwide has partnered with Finland-based CRO Medfiles, which specializes in pharmaceutical development and analytical services, clinical trial support, health economics and regulatory affairs.

More... »

Clinipace Worldwide acquires Paragon Biomedical

Tuesday, September 25, 2012 07:00 AM

Clinipace Worldwide, a global digital contract research organization (dCRO), and Paragon Biomedical, a global, full-service CRO, have jointly announced a definitive merger agreement under which Morrisville, N.C.-based Clinipace Worldwide has acquired all outstanding shares of privately-held, Irvine, Calif.-based Paragon and its subsidiaries.

More... »

Clinipace Worldwide to manage Prometheus oncology program

Wednesday, July 18, 2012 01:29 PM

Morrisville, N.C.-based Clinipace Worldwide, a global digital research organization (dCRO), said Prometheus Laboratories, a specialty pharmaceutical and diagnostic company, has awarded it an Oncology Program.  Immediate plans are commencing for two metastatic melanoma studies.  

More... »

Clinipace names VP, European clinical operations

Wednesday, November 2, 2011 12:17 PM

Clinipace Worldwide has named Andrea Schiefer, Ph.D., vice president of European clinical operations and executive director of pharmacovigilance. In this position, Andrea reports directly to Kurt Pfister, chief executive officer of European operations at Clinipace Worldwide, and is responsible for providing leadership and direction to the project management, clinical monitoring and safety groups within the European clinical operations unit at Clinipace Worldwide.

More... »

Larus joins Clinipace Worldwide

Tuesday, October 18, 2011 02:04 PM

Clinipace Worldwide has named John Larus executive vice president of clinical operations. In this newly created position, John reports directly to Chris Porter, chief operating officer, and is responsible for providing leadership and direction to the project management, clinical monitoring and safety groups within the U.S. clinical operations unit.

More... »

Clinipace secures $15M in Series C financing

Tuesday, September 27, 2011 12:34 PM

Clinipace Worldwide has closed a $15M Series C round of funding led by Morgan Stanley Expansion Capital of San Francisco, CA.  Existing investors, including Hatteras Venture Partners of Durham, NC, and Brook Private Equity Advisors of Boston, MA, also participated in this most recent round of funding.

More... »

Clinipace acquires PFC Pharma Focus

Monday, May 23, 2011 08:47 AM

While industry news has been dominated by medium to large CRO acquisitions, consolidation is taking place in the smaller end of the market, too. Last Wednesday morning, CRO Clinipace Worldwide announced it has acquired Swiss CRO PFC Pharma Focus.

More... »

CRO Clinipace Worldwide acquires PFC Pharma Focus

Wednesday, May 18, 2011 05:01 AM

Recent industry news has been dominated by stories of medium to large CROs acquiring one another or being acquired by investment companies. But consolidation is taking place in the smaller end of the market, too. This morning, CRO Clinipace Worldwide announced it has acquired Swiss CRO PFC Pharma Focus.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 2

Roche's $8.3B InterMune buy continues its buying spree with 'bolt-on' deal, fueling record M&A activity

FDA action plan seeks to close gap in women and minority patient representation in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs